EMAIL THIS PAGE TO A FRIEND

Nature communications

Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss.


PMID 25825024

Abstract

Immunglobulin G (IgG) sialylation represents a key checkpoint that determines the engagement of pro- or anti-inflammatory Fcγ receptors (FcγR) and the direction of the immune response. Whether IgG sialylation influences osteoclast differentiation and subsequently bone architecture has not been determined yet, but may represent an important link between immune activation and bone loss. Here we demonstrate that desialylated, but not sialylated, immune complexes enhance osteoclastogenesis in vitro and in vivo. Furthermore, we find that the Fc sialylation state of random IgG and specific IgG autoantibodies determines bone architecture in patients with rheumatoid arthritis. In accordance with these findings, mice treated with the sialic acid precursor N-acetylmannosamine (ManNAc), which results in increased IgG sialylation, are less susceptible to inflammatory bone loss. Taken together, our findings provide a novel mechanism by which immune responses influence the human skeleton and an innovative treatment approach to inhibit immune-mediated bone loss.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

09972
3-Nitrotetrazolium blue chloride, ≥75% (AT)
C40H30Cl2N10O6
50553
α-tri-Calcium phosphate, Reagent for transient & stable DNA transfections
Ca3O8P2
09830
Ammonium bicarbonate, BioUltra, ≥99.5% (T)
CH5NO3
C8271
Cytidine-5′-monophospho-N-acetylneuraminic acid sodium salt, ≥85% (HPLC)
C20H30N4NaO16P
G0750
D-(+)-Galactose, ≥99%
C6H12O6
G0625
D-(+)-Galactose, ≥98%
C6H12O6
G6404
D-(+)-Galactose, BioXtra, pH 5.0-7.0 (20 °C, 1 M in H2O), ≥99%
C6H12O6
G5388
D-(+)-Galactose, powder, anhydrous, BioReagent, suitable for cell culture, suitable for insect cell culture
C6H12O6
48260
D-(+)-Galactose, for microbiology, ≥99.0%
C6H12O6
15522
D-(+)-Galactose, meets analytical specification of Ph. Eur., BP
C6H12O6
ARK2181
D-(+)-Mannose, PharmaGrade, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production
C6H12O6
M2069
D-(+)-Mannose, from wood, ≥99%
C6H12O6
M8574
D-(+)-Mannose, synthetic, ≥99%
C6H12O6
M6020
D-(+)-Mannose, powder, BioReagent, suitable for cell culture
C6H12O6
63579
D-(+)-Mannose, BioUltra, ≥99.5% (sum of enantiomers, HPLC)
C6H12O6
63580
D-(+)-Mannose, for microbiology, ≥99%
C6H12O6
63582
D-(+)-Mannose, for microbiology, ≥99.0% (sum of enantiomers, HPLC)
C6H12O6
M4625
D-(+)-Mannose
C6H12O6
1287700 Galactose, United States Pharmacopeia (USP) Reference Standard
C6H12O6
PHR1206
Galactose, Pharmaceutical Secondary Standard; Certified Reference Material
C6H12O6
G0050000
Galactose, European Pharmacopoeia (EP) Reference Standard
C6H12O6
ARK2176
Galactose, plant-derived, PharmaGrade, USP/NF, Ph Eur, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.
C6H12O6
69947
MOPS, BioUltra, for molecular biology, ≥99.5% (T)
C7H15NO4S
T4375
Tetrazolium Blue Chloride, used in colorimetric determination of reducing compounds
C40H32Cl2N8O2
88190
Tetrazolium Blue Chloride, indicator for germination, for microbiology, ≥90% (T)
C40H32Cl2N8O2